Philippe Laffont’s Novavax NVAX Stock Holding History

Philippe Laffont’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.1M	Hold	3,836,986	–	–	0.07%	43
2026 Q1	$31.2M	Buy	+3,836,986	New	+$34.8M	0.11%	42
2025 Q4	–	Sell	-3,836,986	Closed	-$33.3M	–	67
2025 Q3	$33.3M	Hold	3,836,986	–	–	0.08%	54
2025 Q2	$24.2M	Hold	3,836,986	–	–	0.07%	53
2025 Q1	$24.6M	Buy	+3,836,986	New	+$31.7M	0.11%	45
2024 Q4	–	Sell	-2,224,319	Closed	-$28.1M	–	84
2024 Q3	$28.1M	Sell	2,224,319 -400,596	-15%	-$5.17M	0.1%	58
2024 Q2	$33.2M	Buy	2,624,915 +1,105,321	+73%	+$11.1M	0.13%	46
2024 Q1	$7.26M	Hold	1,519,594	–	–	0.03%	80
2023 Q4	$7.29M	Buy	+1,519,594	New	+$9.3M	0.03%	81
2023 Q3	–	Sell	-1,039,123	Closed	-$7.72M	–	96
2023 Q2	$7.72M	Sell	1,039,123 -726,936	-41%	-$5.72M	0.04%	74
2023 Q1	$12.2M	Buy	1,766,059 +1,462,000	+481%	+$13.5M	0.08%	57
2022 Q4	$3.13M	Sell	304,059 -243,496	-44%	-$4.3M	0.04%	66
2022 Q3	$9.97M	Sell	547,555 -694,161	-56%	-$30.1M	0.12%	66
2022 Q2	$63.9M	Buy	1,241,716 +358,270	+41%	+$18.6M	0.77%	31
2022 Q1	$65.1M	Buy	+883,446	New	+$78.8M	0.48%	33

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Philippe Laffont's NVAX Position: Q2 2026 in Review

Philippe Laffont held its Novavax (NVAX) position steady in Q2 2026 at 3,836,986 shares worth $36.1M. The position accounts for 0.07% of the portfolio, ranked #43.

Philippe Laffont first reported a position in NVAX in Q1 2022 and has held it in 15 quarters since. The position peaked at $65.1M in Q1 2022. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Philippe Laffont held 3,836,986 shares of Novavax worth $36.1M as of Q2 2026.
Philippe Laffont left its Novavax share count unchanged in Q2 2026.
Novavax made up 0.07% of Philippe Laffont's portfolio in Q2 2026, its #43 holding.
Philippe Laffont first reported a position in Novavax in Q1 2022 and has held it in 15 quarters since.
Philippe Laffont's Novavax position peaked at $65.1M in Q1 2022.
268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Coatue Management's 13F filing for Q2 2026, filed 14 Aug 2026.